Related Experiment Video

Updated: Jun 26, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.2K

A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals

Mangesh Tiwaskar1, Ketan K Mehta2, Prabhu Kasture3

  • 1Consultant Physician and Diabetologist, Department of Diabetology, Shilpa Medical Research Centre, Mumbai, Maharashtra, India.

The Journal of the Association of Physicians of India
|May 13, 2024
PubMed

Insights

Olmesartan medoxomil (OLM) effectively manages hypertension (HTN) and related cardiovascular diseases. This angiotensin II receptor blocker offers long-lasting blood pressure control and good tolerability in monotherapy and combination treatments.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Angiotensin receptor blockers (ARBs) have been a cornerstone in managing hypertension (HTN) and cardiovascular (CV) diseases for over 30 years.
  • Olmesartan medoxomil (OLM) is a potent angiotensin II type 1 (AT1) receptor antagonist with demonstrated long-lasting efficacy and safety.

Purpose of the Study:

  • To review the clinical implications of Olmesartan medoxomil (OLM) in hypertension management.
  • To evaluate OLM's efficacy and tolerability as both monotherapy and combination therapy.

Main Methods:

  • Review of clinical trials and studies on Olmesartan medoxomil.
  • Analysis of blood pressure reduction, tolerability, and adherence data.

Main Results:

  • OLM demonstrates consistent 24-hour blood pressure (BP) reduction.
  • It is well-tolerated in monotherapy and combination therapies with thiazide diuretics or calcium channel blockers.
  • Fixed single-pill formulations of OLM-based combinations show high adherence and favorable safety profiles.

Conclusions:

  • Olmesartan medoxomil is a valuable and effective treatment option for adult patients with hypertension.
  • Its consistent efficacy and good tolerability support its use in both monotherapy and combination strategies.
  • OLM offers optimal clinical implications for managing diverse patient subgroups with HTN.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

4.7K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

20.4K

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
715
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
601
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
620
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
672